In this study, we investigated the clinical and biological implications of PGAP3 co‐amplification with ERBB2 in gastric tumorigenesis in vitro, and demonstrated that the aberrant expression of these genes is associated with the malignancy of GC cells. The gene discussed is PGAP3; the disease is gastric cancer.